Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001377
What this trial is testing

Familial Prostate Cancer

Who this might be right for
Neoplastic Syndromes, HereditaryProstatic Neoplasms
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Study completedNCT00027781
What this trial is testing

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 37
Not applicableStudy completedNCT03744494
What this trial is testing

Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer

Who this might be right for
Prostate CancerQuality of LifeOrchiectomy
University College Hospital, Ibadan 63
Not applicableLooking for participantsNCT07300631
What this trial is testing

SpaceOAR Post-Market Registry Study

Who this might be right for
Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust 320
Testing effectiveness (Phase 2)UnknownNCT06001255
What this trial is testing

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Who this might be right for
Metastasis Castration Resistant Prostate Cancer(mCRPC)
Hansoh BioMedical R&D Company 120
Not applicableStudy completedNCT04337060
What this trial is testing

Open Radical Prostatectomy and Erector Spinae Plane Block

Who this might be right for
Prostate CancerAnesthesia, LocalPain, Postoperative
BURHAN DOST 52
Testing effectiveness (Phase 2)Study completedNCT04742959
What this trial is testing

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaHER2-negative Breast Cancer+8 more
TransThera Sciences (Nanjing), Inc. 203
Testing effectiveness (Phase 2)Study completedNCT04530552
What this trial is testing

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Who this might be right for
Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT02833038
What this trial is testing

Effect of Intravenous Magnesium During Robot Assisted Prostatectomy

Who this might be right for
Prostatic Neoplasms
Ajou University School of Medicine 60
Large-scale testing (Phase 3)UnknownNCT00043576
What this trial is testing

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Who this might be right for
Prostate Cancer
Novacea 250
Large-scale testing (Phase 3)Looking for participantsNCT03851640
What this trial is testing

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Who this might be right for
MCRPC
Hinova Pharmaceuticals Inc. 417
Large-scale testing (Phase 3)Study completedNCT00946920
What this trial is testing

A Trial of Degarelix in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 859
Not applicableStudy completedNCT04341324
What this trial is testing

Effect of ADT in Chinese Male With Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 60
Not applicableUnknownNCT04228055
What this trial is testing

Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)

Who this might be right for
Prostate Cancer
University of Arizona 36
Testing effectiveness (Phase 2)Looking for participantsNCT05168618
What this trial is testing

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
University of Utah 33
Not applicableStudy completedNCT03278197
What this trial is testing

Evaluation of a Web-based Decision Aid Tool for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Maastricht Radiation Oncology 11
Not applicableLooking for participantsNCT06612047
What this trial is testing

Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT06798558
What this trial is testing

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate Adenocarcinoma
Hackensack Meridian Health 54
Not applicableNot Yet RecruitingNCT06453785
What this trial is testing

Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection

Who this might be right for
Prostate Cancer
Imperial College London 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT02893917
What this trial is testing

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma With Neuroendocrine DifferentiationCastration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+3 more
National Cancer Institute (NCI)
Next Page
90